Posts

The Risky Gamble of Ottobock's CEO

Hans Georg Näder, the extroverted CEO and owner of the German global market leader in prosthetics, has already had to cancel the IPO twice. The third attempt must succeed, or trouble looms. Ottobock's engagement in Russia also raises questions.

Inside Ottobock: Prosthetics Billionaire Hans Georg Näder Dipped into Company Coffers Despite Losses, Withdrawing Millions

Over the past decade, billionaire Hans Georg Näder has extracted half a billion euros from the family-owned Ottobock enterprise. Näder's withdrawals frequently exceeded profits and persisted even when the company reported losses. Ottobock has been preparing for an IPO for years, with its compelling corporate narrative outshining its financial performance.

Hans-Georg Näder's Green Promises: The Prosthetics Billionaire Appears to Take a Relaxed Approach to Sustainability in Shipbuilding

Näder sells his Pink Gin yacht and opts for a fully motorized ship, the SeaXplorer Pink Shadow, equipped with a ship diesel tank holding 188,000 liters and an estimated consumption of 38 liters per nautical mile

After EQT Deal, Ottobock Owner Näder Sells One of His IT Subsidiary Companies

The company Sycor is selling its subsidiary IQ Solutions to the newly established IT group Cohemi.

Hans Georg Näder's Risky Buyback

Manager Magazin, 8 April 2024 “Hans Georg Näders riskanter Rückkauf”

Ottobock Owner: We are ready for the IPO, we are just waiting for the right environment

The prosthetics manufacturer Ottobock is now back in 100 percent ownership of the Näder family. The 105-year-old family enterprise announced this on Thursday evening. It has taken out a total of 1.1 billion euros in loans from credit funds to buy out the financial investor EQT, which has been involved since 2017.

Ottobock Confirms Repurchase of Shares from EQT

Manager Magazin, 13 March 2024 “Ottobock Confirms Repurchase of Shares from EQT”

Näder Family Plans to Repurchase 20% Stake in Ottobock

Näder Family Plans to Repurchase 20% Stake in Ottobock. After six years, the investor EQT is parting ways with the prosthetics manufacturer. The closing is planned for January 2024.